SanjayGurunathanMD

PubMed

• 1 citations
  Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.
  Ford, E., Li, A., Laing, K., Dong, L., Diem, K., Jing, L., Basu, K., Ott, M., Tartaglia, J., Gurunathan, S., Reid, J., Ecsedi, M., Chapuis, A., Huang, M., Magaret, A.,...> ;Medrxiv. 2024 Feb 1
• Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
  Kombo F N'guessan, Kawthar Machmach, Isabella Swafford, Margaret C Costanzo, Lindsay Wieczorek, Dohoon Kim, Siriwat Akapirat, Victoria R Polonis, Punnee Pitisuttithum,...> ;Frontiers in Immunology. 2024 Jan 1
• "Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".
  Monica Anne McArthur, Siham Bchir, Estelle Dubois, Lucia Gan, Eric Gerchman, Sandeep Gupta, Olga Liabis, Lucia Perez, Fabienne Roche, Gustavo Vasquez, Betzana Zambrano...> ;Human Vaccines & Immunotherapeutics. 2023 Dec 15
• Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
  Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C deCamp, Zonglin He, Nicole Grunenberg, Faatima Laher Omar, Kelly E Seaton, Laura Polakowski,...> ;The Journal of Infectious Diseases. 2023 Oct 5
• 2 citations
  Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
  Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Amit Suresh Bhate, Tatiana Beresnev, Matthew I Bonapart...> ;Eclinicalmedicine. 2023 Oct 1
• 3 citations
  Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, pl...
  Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Kwaku Poku Asante, Amit Suresh Bhate, Tatiana Beresnev,...> ;The Lancet. Respiratory Medicine. 2023 Nov 1
• 7 citations
  Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phas...
  Guy de Bruyn, Joyce Wang, Annie Purvis, Martin Sanchez Ruiz, Haritha Adhikarla, Saad Alvi, Matthew I Bonaparte, Daniel Brune, Agustin Bueso, Richard M Canter, Maria An...> ;Eclinicalmedicine. 2023 Aug 1
• 2 citations
  Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability.
  Zhanna Shubin, Sherry Stanfield-Oakley, Jiraporn Puangkaew, Punnee Pitisutthithum, Sorachai Nitayaphan, Sanjay Gurunathan, Faruk Sinangil, Suwat Chariyalertsak, Nittay...> ;AIDS. 2023 Aug 1
• 2 citations
  ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.
  Margaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, Siriwat Akapirat, Zhanna Shubin, Dohoon Kim, Lindsay Wieczorek, Victoria R Polonis, Hung V Trinh, Mangal...> ;JCI Insight. 2023 May 8
• 11 citations
  Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
  Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Kwaku Poku Asante, Amit Suresh Bhate, Tatiana Beresnev,...> ;Medrxiv. 2023 Jan 13
• 8 citations
  The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022.
  Saranya Sridhar, Roman M Chicz, William Warren, Jim Tartaglia, Stephen Savarino, Sanjay Gurunathan, Jean-Francois Toussaint> ;Nature Communications. 2022 Oct 2
• 3 citations
  Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
  Rasmi Thomas, Danaya Chansinghakul, Kriengsak Limkittikul, Peter B. Gilbert, Weerawan Hattasingh, Zoe Moodie, Shida Shangguan, Carina Frago, Wut Dulyachai, Shuying Sue...> ;Human Immunology. 2021 Oct 8
• 74 citations
  Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dos...
  Paul A. Goepfert, Bo Fu, Anne-Laure Chabanon, Matthew Bonaparte, Matthew Davis, Brandon Essink, Ian Frank, Owen Haney, Helene Janosczyk, Michael C. Keefer, Marguerite ...> ;The Lancet. Infectious Diseases. 2021 Apr 19
• 30 citations
  Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
  Guy de Bruyn, David L. Gordon, Theodore Steiner, Paul A. Tambyah, Catherine Cosgrove, Mark G. Martens, Ehab Bassily, Eng Soon Chan, Dhaval M Patel, Josh Chen, Julián T...> ;The Lancet. Infectious Diseases. 2021 Feb 1
• 15 citations
  Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines.
  Virginie Rozot, Elisa Nemes, Hennie Geldenhuys, Munyaradzi Musvosvi, Asma Toefy, Frances Rantangee, Lebohang Makhethe, Mzwandile Erasmus, Nicole Bilek, Simbarashe Mabw...> ;Communications Biology. 2020 Oct 9
• 16 citations
  Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
  Ming Zhu, Saranya Sridhar, Rosalind Hollingsworth, Ayman Chit, Tammy Kimball, Kerry Murmello, Michael Greenberg, Sanjay Gurunathan, Josh Chen> ;Contemporary Clinical Trials. 2020 Jul 1
• 2 citations
  Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial.
  Joyce Ojeda, José Luis Arredondo, Perla Salcedo, Mercedes Paredes-Paredes, Martin Dupuy, Céline Petit, Anne Laure Chabanon, Enrique Rivas, Sanjay Gurunathan, Iris De B...> ;Human Vaccines & Immunotherapeutics. 2020 Jun 2
• The promise of mRNA vaccines: a biotech and industrial perspective.
  Nicholas A C Jackson, Kent E Kester, Danilo Casimiro, Sanjay Gurunathan, Frank DeRosa> ;NPJ Vaccines. 2020 Jan 1
• 32 citations
  Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial i...
  Stephanie Pepin, Martin Dupuy, Charissa Borja-Tabora, May Montellano, Lulu Bravo, Jaime Santos, Jo-Anne A. de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Migue...> ;Vaccine. 2019 Mar 22
• Join now to see all